Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-03-20
2007-03-20
Henley, III, Raymond J. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S320000, C514S648000
Reexamination Certificate
active
10601481
ABSTRACT:
The present invention provides methods of inducing contraception which includes delivering to a female a composition containing a compound of formula I or formula II, or tautomers thereof, in a regimen which involves delivering one or more of a selective estrogen receptor modulator, wherein formula I is:and wherein R1–R5and Q1are defined as described herein. Methods of providing hormone replacement therapy and for treating carcinomas, dysfunctional bleeding, uterine leiomyomata, endometriosis, and polycystic ovary syndrome is provided which includes delivering a compound of formula I and a selective estrogen receptor modulator are also described.
REFERENCES:
patent: 6258802 (2001-07-01), Hodgen
patent: 6355648 (2002-03-01), Fensome et al.
patent: 6407101 (2002-06-01), Collins et al.
patent: 6436929 (2002-08-01), Zhang et al.
patent: 6509334 (2003-01-01), Zhang et al.
patent: 6521657 (2003-02-01), Fensome et al.
patent: 6583145 (2003-06-01), Fensome et al.
patent: 2002/0061875 (2002-05-01), Gast et al.
patent: 2002/0169198 (2002-11-01), Fensome et al.
patent: 2003/0083322 (2003-05-01), Kraemer et al.
patent: 2003/0092711 (2003-05-01), Zhang et al.
patent: 2310660 (1997-09-01), None
patent: WO-85/00519 (1985-02-01), None
patent: PCT WO 00/66555 (2000-11-01), None
patent: PCT WO 00/66570 (2000-11-01), None
patent: WO-00/66571 (2000-11-01), None
patent: WO 00/66581 (2000-11-01), None
Zhang et al., “Potent Nonsteroidal Progesterone Receptor Agonists: Synthesis and SAR study of 6-Aryl Benzoxazines”, Bioorg. Med. Chem. Lett., 12: 787-790 (Mar. 11, 2002).
Fensome et al., “Synthesis and Structure-Activity Relationship of Novel 6-Aryl-1,4-dihydrobenzo[d][1,3]oxazine-2-thiones as Progesterone Receptor Modulators Leading to the Potent and Selective Nonsteroidal Progesterone Receptor Agonist Tanaproget”, J. Med. Chem., 48: 5092-5095 (Aug. 11, 2005).
Zhang et al., “Novel 6-Aryl-1,3-dihydrobenzo[d][1,3]oxazine-2-thiones as Potent, Selective, and Orally Active Nonsteroidal Progesterone Receptor Agonists”, Bioorg. Med. Chem. Lett., 13:1313-1316 (Apr. 7, 2003).
Winneker et al., “Nonsteroidal Progesterone Receptor Modulators: Structure Activity Relationships”, Sem. Reprod. Med., 23(1): 46 (Feb. 2005).
Fensome Andrew
Grubb Gary S.
Harrison Diane Deborah
Kern Jeffrey Curtis
Terefenko Eugene Anthony
Henley III Raymond J.
Howson and Howson
Milowsky Arnold S.
Wyeth
LandOfFree
Methods of treating hormone-related conditions using... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treating hormone-related conditions using..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating hormone-related conditions using... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3763055